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CASE REPORT
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Abstract: Spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA) is a rare autosomal
recessive hereditary skeletal disease, and mutations in WISP3 are responsible for its onset. WISP3 is essential
for maintaining cartilage integrity mainly by regulating the expression of collagen II, and mutations of WISP3
linked to SEDT-PA can compromise this function and lead to cartilage loss, which is frequently misdiagnosed
as juvenile idiopathic arthritis. It is characterized by arthralgia, joint contractures, bony swelling of
metacarpophalangeal and interphalangeal joints and platyspondyly. Clinical and laboratory signs of joint
inflammation such as synovitis, a high erythrocyte sedimentation rate and an elevated C-reactive protein level
are usually absent. Although the disease begins early in life (usually between 3 and 8 years of age), the
diagnosis may be delayed. In the present case report, we describe a female patient diagnosed with SEDT-PA
at the age of 40 years, although she had been exhibiting the typical radiological and clinical features of the
disease since the age of 8 years. Genetic disorders like SEDT-PA may also have rheumatological involvement,
and thus should be kept in mind in the differential diagnosis of inflammatory joint diseases.
Key Words: Spondyloepiphyseal dysplasia, pseudorheumatoid arthropathy, progressive arthropathy,
osteochondrodysplasias

Tan›s› Gecikmiﬂ Progresif Artropati ile Seyreden Spondiloepifizeal Displazi
Tarda
Özet: Progresif artropati ile seyreden spondiloepifizeal displazi tarda (“Spondyloepiphyseal dysplasia tarda
with progressive arthropathy” SEDT-PA) otozomal resesif kal›t›ml› nadir bir iskelet hastal›¤›d›r ve WISP3
genindeki mutasyonlar SEDT-PA’n›n baﬂlang›c›ndan sorumludur. WISP3, kartilaj bütünlü¤ünün
sürdürülmesinde gerekli olan bir gendir. Kollajen II’nin ekspresyonunu regüle ederek, kartilaj bütünlü¤ünün
korunmas›ndan sorumludur. SEDT-PA ile ilgili olan WISP3 mutasyonlar›, bu fonksiyonu engelleyerek kartilaj
kayb›na sebep olmakla birlikte, genellikle hastalar bu sebeple juvenil idiyopatik artrit olarak yanl›ﬂ tan›
almaktad›rlar. Hastal›k artralji, eklem kontraktürü, metakarpofalangeal ve interfalangeal eklemlerde kemiksi
ﬂiﬂlikler ve platispondili ile karakterizedir. Sinovit gibi, eklem inflamasyonunun klinik ve laboratuvar iﬂaretleri
olan, yüksek eritrosit sedimentasyon h›z› ve yükselmiﬂ C-reaktif protein seviyeleri genellikle bulunmamaktad›r.
Hastal›k erken yaﬂlarda baﬂlamakla birlikte (genellikle 3-8 yaﬂ aras›), tan›s› gecikmiﬂ olabilir. Mevcut vaka
raporunda, hastam›z 8 yaﬂ›ndan beri SEDT-PA’n›n tipik radyolojik ve klinik özelliklerini göstermesine ra¤men,
40 yaﬂ›nda iken SEDT-PA olarak taraf›m›zdan tan›mlanm›ﬂt›r. SEDT-PA gibi genetik hastal›klar, romatolojik
bulgulara da sahip olabildi¤inden inflamatuar eklem hastal›klar›n›n ay›r›c› tan›s›nda ak›lda bulundurulmal›d›rlar.
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Spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA) is a single gene disorder that is inherited in an autosomal recessive manner. Alternative names
of the disease are “progressive pseudorheumatoid arthropathy of childhood (PPAC)” and
“progressive pseudorheumatoid dysplasia (PPD)” (MIM 208230) (1,2). The first cases
were described in 1980 and 1982 under the designation “progressive pseudorheumatoid arthritis of childhood” (3). In 1997, SEDT-PA was classified in the International
Nomenclature and Classification of the Osteochondrodysplasias, and was listed as an
autosomal recessive disorder in group 10: “other spondylo-(meta)-physeal dysplasias
[SE(M)D]” (4).
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Mutations in WNT-1 inducible secreted protein 3
(WISP3) cause SEDT-PA (5). WISP3, a member of the
connective tissue growth factor/cysteine-rich protein
61/nephroblastoma overexpressed growth factor family,
maps to chromosome 6q21-22 and encodes a protein
containing 354 amino acids. WISP3 is important in many
biological pathways including the development of the
skeleton, nerve fibers, and blood vessels through the regulation of cell proliferation and differentiation (6). WISP3
can function as a ligand and signal via autocrine and/or
paracrine modes upon being secreted by chondrocytes
(7). Recently, it was shown that WISP3 can regulate the
sensitivity of mammary epithelial cells to insulin-like
growth factor-I (IGF-I) and alter the activation of IGF-I
receptor (IGF-IR) signaling pathways (6). In SEDT-PA,
the mutant WISP3 triggers the phenotypic changes of the
articular chondrocytes by losing the function of inhibiting
IGF-I. IGF-I then stimulates the articular chondrocytes to
undergo hypertrophic and terminal differentiation, as in
endstage osteoarthritis (5).
The main clinical features are arthralgia, joint contractures, enlarged metacarpophalangeal and interphalangeal joints, platyspondyly and short stature (8). The
disease generally begins between the ages of 3-8 years
with abnormal gait and fatigability (9). The nature of the
disease is progressive and clinically indifferent from juvenile idiopathic arthritis (JIA) (10). Though rare, because
of this resemblance, diagnosing this entity is important to
prevent inappropriate treatment (1). In the present case
report, we describe a female patient diagnosed with
SEDT-PA as late as at the age of 40 years, although she
had been displaying the typical clinical and radiological
features of the disease since childhood.
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After the complete description of the study to the subjects, including photographs, written informed consent
was obtained and approval received by the local ethics
committee.
Our patient’s first symptoms began as difficulty in
walking and genu valgum deformity of both knees at the
age of eight years. However, she suffered progressive
stiffness and pain in all joints and a generalized muscle
weakness in the following years. She was diagnosed as
JIA and started on antirheumatic drug therapy but her
condition deteriorated further.
The height of the patient was 133 cm and her weight
was 61 kg. Her vital signs were stable. Her systemic
examination was normal, including the eyes, chest,
abdomen and cardiovascular and genitourinary system
examinations. Her intelligence was normal. Several symptoms were diagnosed in the musculoskeletal system, and
the spirometric tests were found abnormal, showing
restrictive feature. She had a short stature with increased
thoracic kyphosis and lumbar lordosis. Shoulders, elbows
and wrists were minimally painful and the range of
motion (ROM) was limited to 25% in the shoulders,
elbows and wrists. Metacarpophalangeal joints and interphalangeal joints were painful. Bilateral mild flexion
deformities were present in interphalangeal joints where
spindle-shaped swelling was also prominent. She was
unable to make a fist (Figure 2). Hips were painful and
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II.

Case Report
A 40-year-old female patient admitted to the outpatient clinic of the Chest Department with breathlessness
complaints. Medical consultation was requested from our
department for progressive deformity in her joints. Parents of the patient were first cousins. She had three sisters and one brother. The 42-year-old brother was
reported as having the same clinical characteristics as our
patient; he did not agree to be consulted due to his psychological status. Our patient is married and has two
healthy children, a boy and a girl. The pedigree of our
patient is shown in Figure 1.
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Figure 1. The pedigree of our proband.

Arrow indicates the proband. Roman numerals/figures show the
generations. Arabic numerals show individuals.
■: Healthy male. ●: Healthy female.
■: Affected male. ●: Affected female.
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Figure 2. Flexion deformity and ‘apparent’ swelling of proximal interphalangeal joints.

ROM was severely limited. Knees were painful, ROM was
limited and there were bilateral genu valgum deformities
(Figure 3). Neurologic examination was normal other
than a generalized muscular weakness, thought to be due
to disuse.
Radiological evaluation was made by radiology consultants of our hospital. Lateral thoracic spine radiograph
revealed increased kyphosis, generalized platyspondyly
with increased anteroposterior (AP) diameters and loss of
height in vertebral bodies. Hyperostotic bone deposited
on the posterior two-thirds of the end plates was evident
in the lumbar spine. On AP lumbar spine radiograph, scoliosis was detected (Figure 4). AP radiograph of the hip
demonstrated bilateral narrow and irregular joint spaces
and subchondral sclerosis, with widened and flattened
femoral heads (Figure 5).
Radiographs of the knees revealed osseous enlargement of the tibiofemoral joints. Bilateral tibiofemoral and
patellofemoral joint spaces were narrowed and joint contours were irregular (Figures 6 and 7). Radiographs of
the hands showed general narrowing of the joint spaces
and osseous enlargement of the basis of the metacarpal
bones and metacarpophalangeal, proximal and distal
interphalangeal joints (Figure 8). There was diminished
density of the bony structures compatible with osteoporosis on all X-rays, which was confirmed by dual energy X-ray absorptiometry (DEXA).
The results of a urine analysis, complete blood count
and routine blood chemistry (including serum creatinine,
calcium, phosphorus, alkaline phosphatase, aspartate
aminotransferase and alanine aminotransferase) were

Figure 3. Osseous enlargement of the tibiofemoral joints.

normal. The thyroid stimulating hormone, follicle-stimulating hormone, luteinizing hormone and testosterone
levels were normal. Anti-streptolysin O (ASO) titer was
284 IU/ml (N: 0-200 IU/ml), C-reactive protein (CRP)
31.7 mg/L (N: 0-6 mg/L), erythrocyte sedimentation rate
(ESR) 20 mm/hr, and rheumatoid factor, antinuclear
antibody, and anti-dsDNA were negative. C3, C4,
immunoglobulins and thyroid function tests, and parathyroid hormone level were normal. Hepatitis markers and
group agglutination tests (Salmonella, Shigella) were negative. All cultures were negative, including throat, stool,
urine and blood cultures.
She was diagnosed as SEDT-PA and was treated with
nonsteroidal anti-inflammatory drugs (NSAIDs) and
advised about physical therapy, and her pain diminished
to a significant degree. The family and the patient were
informed about the disease, joint protection and exercise
programs.
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Figure 6. AP radiographs of the bilateral knees show generalized
osteopenia and osseous enlargement of the tibiofemoral
joints. Bilateral tibiofemoral joint spaces are extremely
narrow and joint contours are irregular.

Figure 4. Lateral thoracic spine radiograph shows generalized
osteopenia, increased kyphosis, generalized platyspondyly
with increased AP diameters and loss of height in vertebral
bodies. Note hyperostotic bone deposited on the posterior
lumbar spine.

Figure 5. AP radiograph of the hip demonstrates generalized
osteopenia, bilateral narrow and irregular joint spaces and
subchondral sclerosis with widened and flattened femoral
heads.
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Figure 7. Lateral radiograph of the knee reveals that the
patellofemoral joint space is narrow.
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Figure 8. The hand radiographs reveal general narrowing of the joint
spaces and osseous enlargement in the metacarpal bones and
metacarpophalangeal and proximal-distal interphalangeal
joints and subchondral sclerosis in the second
metacarpophalangeal joint.

Discussion
SEDT-PA is a rare hereditary disorder with autosomal
recessive inheritance with symptoms consisting of stiffness, swelling of joints, motor weakness and joint contractures. (5,11). Although the prevalence of SEDT-PA in
Turkey is not precisely known, it is apparently rare in
western countries, with an incidence of one per million in
the United Kingdom. It is probably more frequent in the
Middle East and Gulf States, with more than two-thirds
of the reported patients belonging to Arab and Mediterranean populations (3,12,13). To the best of our knowledge, this is the eighth case report of a patient with
SEDT-PA from Turkey (8,4).
Spondyloepiphyseal dysplasia can be divided into two
major groups: SED congenita and SED tarda. The autosomal dominant inherited SED congenita form manifests in
the neonatal period and is associated with stigmas such as
pectus carinatum, cleft palate and hypertelorism. Spondyloepiphyseal dysplasia tarda forms (SED tarda [SEDT] and
SED tarda with progressive arthropathy [SEDT-PA]) have
rheumatologic implications. SEDT is inherited as either Xlinked, autosomal recessive or autosomal dominant (14).
The parents of our patient were first–degree cousins, and
a sibling of our patient has the same illness. Therefore,
we suspect autosomal recessive inheritance pattern.
Thus, the proband inherited the mutant allele of the
WISP3 gene from each of the possibly heterozygote parents, with a risk of 1/4 each.
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All case reports published from Turkey are similar in
clinical features and inheritance form. All cases from
Turkey have shown an autosomal recessive inheritance
pattern and parental consanguinity. In all cases, onset of
the symptoms was between the ages of 3 and 8 years.
Also similar were the symptoms such as involvement of
the spine and epiphyses of bones, leading subsequently to
disproportionate short stature and thoracic kyphoscoliosis and pain, swelling and stiffness of multiple articulations, most frequently in the joints of hands, hips, elbows
and feet (1,4,8,13-15). In the SEDT-PA cases presented
from Europe and other countries, all three inheritance
patterns could be seen. X-linked SEDT-PA (MIM 313400)
is characterized by moderate short stature, barrel chest
deformity and minor epiphyseal abnormalities (16).
Initial mapping studies assigned the WISP3 gene
responsible for the disease to the long arm of chromosome 6 (17). WISP3 is a gene of the CCN (cyr61, ctgf,
nov) family that encodes cysteine-rich proteins involved in
cell growth and differentiation (8,3). WISP3, which is
expressed in the proliferating chondrocytes of the fetal
growth plates, may play a major role in bone growth and
cartilage metabolism (3,5). WISP3-mediated regulation
of collagen II and aggrecan corroborates the concept that
WISP3 plays a major role in cartilage growth and maintenance (5). Using a positional candidate approach,
Hurvitz et al. (12) first identified nine different WISP3
gene mutations in affected individuals in 13 SEDT-PA
families (4,6). Yang et al. (5) identified a compound
WISP3 heterozygous gene mutation in a SEDT-PA
patient. They hypothesized that mutant WISP3 loses the
function of IGF-1, which is mediated by the insulin-like
growth factor binding proteins (IGFBPs) domain and promotes the sensitivity to IGF-1 in chondrocytes. IGF-1 triggers the stable articular chondrocyte to undergo hypertrophic and terminal differentiation, which reduces the
expression of types II and IX collagen in SEDT-PA as in
endstage osteoarthritis (5).
SEDT-PA is a rare childhood disease that must be differentiated from JIA to ensure optimal treatment and to
avoid unnecessary exposure to immunosuppressants (3).
Although this 40-year-old patient showed typical clinical
symptoms of SEDT-PA, it was not possible to prevent
cartilage loss due to misdiagnosis. The patient was diagnosed and treated for JIA for a long period.
SEDT-PA is frequently misdiagnosed as JIA, together
with other inherited diseases such as Stickler syndrome,
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a dominantly inherited disease characterized by ocular
abnormalities; Kniest syndrome, an autosomal dominant
condition with facial dysmorphia; and SEDT, which develops at an older age (3). There are at least five case
reports describing its striking similarity to JIA (10,13).
The main reasons for misdiagnosis appear to be onset in
childhood with swelling and restriction of peripheral and
axial joints. However, the absence of arthritic and other
inflammatory findings, especially synovitis, and radiological absence of destructive joint changes should alert the
clinician in excluding JIA and considering other diagnostic
possibilities. Furthermore, a normal ESR and a normal
level of CRP may be additional clues in excluding JIA, in
addition to platyspondyly, which is highly unusual for JIA.
Our patient had been misdiagnosed as JIA due to the
swelling of her proximal interphalangeal and metacarpophalangeal joints and was given NSAIDs until 40 years
of age. We diagnosed SEDT-PA due to the characteristic
radiographic findings such as generalized osteoporosis,
platyspondyly, typical enlargements of the ends of the
short tubular bones of the hands and epiphyseal changes
of the femoral head.
In our case, there were typical radiological findings of
the disease, in addition to osteoporosis as determined on
all X-rays and confirmed by DEXA. This is an interesting
feature of the present case because the patient did not
display any clinical or laboratory signs of other disorders
associated with osteoporosis. We suggest that the
decreased bone density may be a direct consequence of
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SEDT-PA. However, the exact mechanism of this relation
is unclear at present. The absence of systemic signs, history of parental consanguinity and a poor response to
anti-rheumatoid treatment were among the other important features which guided us in diagnosis of SEDT-PA in
our case.
Consequently, SEDT-PA is a rare disease of childhood.
The primarily genetic origin of disorders should be
remembered among childhood rheumatic diseases so that
inappropriate therapy can be prevented and genetic counseling can be offered to the family for the next generations. The family was also enlightened about the risk of
consanguineous marriage, and marriage with persons
carrying the mutations. Our patient has two siblings with
healthy phenotype, but it is expected that they have inherited the mutant gene in heterozygote form from their
homozygote mother. For the next step of our study, we
plan to diagnose the mutant homozygote alleles of the
mother and the heterozygote allele from the siblings by
molecular analysis. We believe that it is necessary to perform molecular analysis of the cases. With this knowledge, we think that more detailed genetic counseling may
be given to the family.
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